1. Risk models for predicting chemotherapy-induced neutropenia;Lyman;Oncologist,2005
2. National Comprehensive Cancer Network. Myeloid Growth Factors (Version 2.2018). Available at: https://www.nccn.org/professionals/physician_gls/pdf/myeloid_growth.pdf. Accessed February 27, 2019.
3. Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA groups study AML-10;Mandelli;J Clin Oncol,2009
4. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update;Taplitz;J Clin Oncol,2018
5. A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia;He;Leuk Lymphoma,2018